Benedict Financial Advisors Inc. grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,124 shares of the pharmacy operator’s stock after purchasing an additional 320 shares during the period. Walgreens Boots Alliance makes up approximately 1.6% of Benedict Financial Advisors Inc.’s investment portfolio, making the stock its 21st biggest position. Benedict Financial Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $3,008,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Hudock Capital Group LLC grew its position in shares of Walgreens Boots Alliance by 0.4% during the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after purchasing an additional 5 shares in the last quarter. Modera Wealth Management LLC grew its position in shares of Walgreens Boots Alliance by 0.4% during the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after purchasing an additional 9 shares in the last quarter. Flagship Harbor Advisors LLC grew its position in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after purchasing an additional 16 shares in the last quarter. Sowell Financial Services LLC grew its position in shares of Walgreens Boots Alliance by 0.6% during the first quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock valued at $218,000 after purchasing an additional 17 shares in the last quarter. Finally, WealthTrust Arizona LLC grew its position in shares of Walgreens Boots Alliance by 0.4% during the second quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock valued at $412,000 after purchasing an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 60.16% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 13.50% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance, Inc. (WBA) Shares Bought by Benedict Financial Advisors Inc.” was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-bought-by-benedict-financial-advisors-inc/1585976.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 78.41 on Monday. The company has a market cap of $83.91 billion, a P/E ratio of 19.80 and a beta of 1.26. The stock’s 50 day moving average is $81.36 and its 200 day moving average is $81.86. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the company posted $1.18 EPS. On average, analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.04%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.

Walgreens Boots Alliance declared that its board has authorized a share buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

Several research firms recently commented on WBA. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and issued a $77.00 price target (down previously from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $92.06.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.